SELLAS Life Sciences (SLS) Inventory (2013 - 2015)

SELLAS Life Sciences (SLS) reported Inventory of $1.4 million for Q2 2015, up 229.33% year-over-year from $433000.0 in Q2 2014, and up 123.86% quarter-over-quarter from $637000.0 in Q1 2015.

SELLAS Life Sciences (SLS) Inventory (2013 - 2015) Analysis & Trends

SELLAS Life Sciences (SLS) has 3 years of Inventory data on file, last reported at $1.4 million in Q2 2015.

  • Inventory for Q2 2015 came in at $1.4 million, up 229.33% year-over-year; the trailing twelve-month figure through Jun 2015 was $1.4 million (up 229.33% YoY), and the FY2014 annual result was $655000.0, up 69.69% from the prior year.
  • Inventory climbed to $1.4 million in Q2 2015 per SLS's latest filing, from $637000.0 in the prior quarter.
  • Over five years, Inventory peaked at $1.4 million in Q2 2015 and troughed at $352000.0 in Q2 2013.
  • A 3-year average of $569111.1 and a median of $433000.0 in 2014 frame the typical range for Inventory.
  • The sharpest annual moves came in 2014 and 2015: Inventory advanced 5.88% in 2014, then jumped 229.33% in 2015.
  • A 3-year view of Inventory shows it stood at $386000.0 in 2013, then jumped by 69.69% to $655000.0 in 2014, then jumped by 117.71% to $1.4 million in 2015.
  • Business Quant data shows SLS's Inventory at $1.4 million in Q2 2015, $637000.0 in Q1 2015, and $655000.0 in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 32.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.77 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 1.43 Mn
Mar 31, 2015 637,000.00
Dec 31, 2014 655,000.00
Sep 30, 2014 450,000.00
Jun 30, 2014 433,000.00
Mar 31, 2014 358,000.00
Dec 31, 2013 386,000.00
Sep 30, 2013 425,000.00
Jun 30, 2013 352,000.00